Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial
Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange Detected- Revision: v3.6.6 replaces v3.6.5 on the page, signaling a minor platform update. This change does not modify study details or user-facing study information.SummaryDifference0.0%

- Check15 days agoChange DetectedAn NIH grant/contract identifier (2016) was added to the study's list of other identifiers, capturing funding information associated with the MOSAIC trial.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.6.5 was added and v3.6.4 was removed, indicating a minor update to the page’s underlying version. It appears to be a background system/format change rather than content changes to the MOSAIC study page.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a new iteration of the page content. It represents a minor update to the page rendering and does not change the information shown.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page revision label was updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the page's versioning information.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, signaling a newer template/version update without changing the study data.SummaryDifference0.0%

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.